Kestra Advisory Services, LLC Atossa Therapeutics, Inc. Transaction History

Kestra Advisory Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$1.6 - $3.27 $16,800 - $34,335	-10,500 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$2.89 - $6.4 $30,345 - $67,200	10,500 New	10,500 $34,000
Q2 2021 Jul 28, 2021	SELL	$1.52 - $8.62 $20,824 - $118,093	-13,700 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$0.92 - $4.33 $12,604 - $59,321	13,700 New	13,700 $28,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.